New combo attack shows promise for tough liver tumors
NCT ID NCT07230080
First seen Nov 17, 2025 · Last updated May 13, 2026 · Updated 20 times
Summary
This study looks at a three-part treatment for people with intermediate to advanced liver cancer that cannot be removed by surgery. The treatment combines a procedure to block the tumor's blood supply (TACE), precise radiation (SBRT), and drugs that help the immune system fight cancer. The goal is to see if this combination shrinks tumors and improves survival, while tracking side effects. 17 adults took part in this single-center study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanfang Hosptial
Guangzhou, China
Conditions
Explore the condition pages connected to this study.